University of Arkansas for Medical Sciences
UAMS BioVentures exists to convert Arkansas medical and biotechnology research into new agreements and new companies focused on improving human healthcare, while providing economic development for Arkansas.
Innovations (44):
- Novel Plasma Biomarker and Marker Profiles For Analysis of Metastatic Disease (11-09) (19 AUG 11)
- New Assay Kit To Quantitatively Measure Methyltransferases and Demthylase Activity in Gene Regulation (11-07) (19 AUG 11)
- Arm Positioning System for Surgery (11-04) (19 AUG 11)
- Immunotherapy for Warts with Human papilloma virus type 57 (HPV 57) antigen in combination with Canada antigen elicits L1-specific T-cell responses and complete resolution of warts (02 JUN 11)
- Novel Radiation Protection and Treatment Compounds (25 MAR 11)
- New Compositions and Methods for Blocking Biofilm Formation and Treating Established Biofilms (19 JAN 11)
- New efficient manufacturing process for Biodegradable Microspheres with controlled release properties for biological pharmaceutical agents (19 JAN 11)
- Essential Amino Acid Supplementation for Recovery from Hip Surgery: Supporting clinical data (20 JUL 10)
- External Uterine Pressure Monitors - Pneumatic TOCO: clinical prototypes tested and support its utility (10-16) (20 JUL 10)
- Control of Pest Insects: Programmed Killing of Females directed by transmission of a Female – Specific Gene from transgenic males (10-06) (22 JUN 10)
Find more innovations
